Enfusion Inc

NYSE ENFN

Download Data

Enfusion Inc Interest Expense To Sales 5 year CAGR for the Trailing 12 Months (TTM) ending June 30, 2023

Enfusion Inc Interest Expense To Sales 5 year CAGR is NA for the Trailing 12 Months (TTM) ending June 30, 2023. The interest expense to sales ratio is a financial metric that represents the proportion of a company's revenue that is used to cover its interest expenses. It is calculated by dividing the company's interest expense by its total revenue. This ratio indicates the financial burden of interest payments on the company's operating income. A higher ratio suggests that a significant portion of the company's revenue is being used to service interest obligations, potentially affecting its profitability. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Enfusion Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2023 was 1.08%, a -62.14% change year over year.
  • Enfusion Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2022 was 2.86%, a -14.96% change year over year.
  • Enfusion Inc Interest Expense To Sales for the Trailing 12 Months (TTM) ending March 31, 2021 was 3.36%.
NYSE: ENFN

Enfusion Inc

CEO Mr. Oleg Movchan
IPO Date Oct. 21, 2021
Location United States
Headquarters 125 South Clark Street, Chicago, IL, United States, 60603
Employees 1,102
Sector Technology
Industry Software - application
Description

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Similar companies

MODN

Model N Inc

NA

NA

PYCR

Paycor HCM Inc

NA

NA

ETWO

E2open Parent Holdings Inc

NA

NA

LAW

CS Disco LLC

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email